Haleon Plc (HLN) – Strategy, SWOT and Corporate Finance Report

Haleon Plc (HLN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Haleon Plc (Haleon) is a manufacturer of consumer healthcare products. The company’s product range includes over-the-counter (OTC) drugs for respiratory, cold and flu, allergy, pain relief, and inflammation, and oral health products, such as toothpaste, toothbrushes, and mouthwash. It also offers nasal decongestants, calcium and vitamin-C supplements, and solutions for heartburn, acid indigestion, and gastric discomfort. Haleon markets its products under Sensodyne, Flonase, Panadol, Caltrate, Tums, Excedrin, Advil, Emergen-C, Fenistil, Polident, Otrivin, Voltaren, Centrum, and Eno brand names. It has business presence across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Haleon is headquartered in Weybridge, Surrey, the UK.

Scope

• Detailed information on Haleon Plc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Haleon Plc in the form of a SWOT analysis

• An in-depth view of the business model of Haleon Plc including a breakdown and examination of key business segments

• News about Haleon Plc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Haleon Plc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Haleon Plc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Haleon Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Noevir Holdings Co Ltd

Dabur India Ltd

Reckitt Benckiser Group Plc

Unilever Plc

Colgate-Palmolive Co

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Haleon Plc - Key Facts

Haleon Plc - Key Employees

Haleon Plc - Key Employee Biographies

Haleon Plc - Major Products and Services

Haleon Plc - History

Haleon Plc - Company Statement

Haleon Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Haleon Plc - Business Description

Product Category: Digestive Health and Other

Overview

Performance

Product Category: Oral Health

Overview

Performance

Product Category: Pain Relief

Overview

Performance

Product Category: Respiratory Health

Overview

Performance

Product Category: Vitamins, Minerals and Supplements

Overview

Performance

Geographical Segment: APAC

Target Markets

Performance

Geographical Segment: EMEA and LatAm

Target Markets

Performance

Geographical Segment: North America

Target Markets

Performance

R&D Overview

Haleon Plc - Corporate Strategy

Haleon Plc - SWOT Analysis

SWOT Analysis - Overview

Haleon Plc - Strengths

Haleon Plc - Weaknesses

Haleon Plc - Opportunities

Haleon Plc - Threats

Haleon Plc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Haleon Plc, Recent Deals Summary

Section 4 – Company’s Recent Developments

Apr 20, 2023: Haleon PLC Results of Haleon 2023 Annual General Meeting

Mar 02, 2023: Haleon Reports 2022 Full year results

Jan 31, 2023: Haleon Announces Board changes

Nov 15, 2022: Haleon Reports Third Quarter 2022 Earnings

Sep 20, 2022: Haleon : Six months ended 30 June 2022

Jul 27, 2022: Haleon is providing half year trading update for the six months ended 30 June 2022

Jul 18, 2022: Completion of the demerger and admission of shares in Haleon

May 30, 2022: GSK announces further appointments to designate Haleon Board

Mar 15, 2022: GSK announces appointments to Designate Haleon Board

Feb 28, 2022: GSK introduces Haleon to investors

Section 5 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Haleon Plc, Key Facts

Haleon Plc, Key Employees

Haleon Plc, Key Employee Biographies

Haleon Plc, Major Products and Services

Haleon Plc, History

Haleon Plc, Other Locations

Haleon Plc, Subsidiaries

Haleon Plc, Key Competitors

Haleon Plc, Ratios based on current share price

Haleon Plc, Annual Ratios

Haleon Plc, Annual Ratios (Cont…1)

Haleon Plc, Annual Ratios (Cont…2)

Haleon Plc, Interim Ratios

Haleon Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Haleon Plc, Performance Chart (2019 – 2022)

Haleon Plc, Ratio Charts

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports